Skip to content
value.today

Medicus Pharma Ltd.

Formerly Interactive Capital Partners Corporation

Total raised
$11 M
1 round on record
Latest round
$11 M
May 2024
First round on record
May 2024
Today
Went public
See the company page

Medicus Pharma Ltd. is listed today as Medicus Pharma Ltd.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Medicus Pharma Ltd.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2024$11 MNo. 1$10 to $50 million

Medicus Pharma Ltd.: Raise no. 1, May 2024

Investors in this round

23 investors had bought by the notice of Jul 8, 2024: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$11 M of $11 M offered
Smallest investment taken
$25,000
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$375,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Carolyn J. Bonner · Executive Officer · President
  • Edward J. Brennan · Executive Officer · Chief Medical Officer
  • Erica J. Monaco · Executive Officer · Chief Operating Officer
  • James J. Quinlan · Executive Officer · Chief Financial Officer
  • Raza J. Bokhari · Executive Officer, Director · Chairman and Chief Executive Officer
  • Barry J. Fishman · Director · Director
  • Frank J. Lavelle · Director · Director
  • Larry Kaiser · Director · Director
  • Robert J. Ciaruffoli · Director · Director
  • Sara R. May · Director · Director
  • William L. Ashton · Director · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Togo PHL Management LLC · Philadelphia, PennsylvaniaSold in PA

Signed by James P. Quinlan, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 8, 2024. Read the notice at the SEC.

equity, debt, optionsSEC
Sep 2023$5 MIssued in a merger or acquisition$2 to $10 million

Medicus Pharma Ltd.: Private sale, Sep 2023

Investors in this round

68 investors had bought by the notice of Oct 13, 2023: 33 accredited, 35 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Ontario, Canada

People named in the notice

  • Carolyn J. Bonner · Executive Officer · President
  • Edward J. Brennan · Executive Officer · Chief Medical Officer
  • James J. Quinlan · Executive Officer · Chief Financial Officer
  • Raza J. Bokhari · Executive Officer, Director · Director and Executive Chairman and Chief Executive Officer
  • Barry J. Fishman · Director · Director
  • Frank J. Lavelle · Director · Director
  • Larry Kaiser · Director · Director
  • Robert J. Ciaruffoli · Director · Director
  • William L. Ashton · Director · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Represents the issuance of 2,463,475 shares at a price of US$2.00 per share.”
  • On a merger: “Medicus Pharma Ltd. consummated a business combination transaction on September 29, 2023, pursuant to which U.S. securityholders of Medicus Pharma Finco Ltd. and SkinJect, Inc. received common shares of Medicus Pharma Ltd.”

Signed by James P. Quinlan, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 13, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medicus Pharma Ltd. chose not to state its revenue in its newest notice of a funding round (Jul 2024).

    SEC Form D · Jul 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2024

That is all the official record says: Medicus Pharma Ltd. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Medicus Pharma Ltd. are on record.

Investors#

No investor of Medicus Pharma Ltd. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 23 investors.

Largest shareholders today

Institutions holding Medicus Pharma Ltd. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medicus Pharma Ltd.
NameRoleNamed in
Carolyn J. BonnerPresidentJul 2024
Edward J. BrennanChief Medical OfficerJul 2024
Erica J. MonacoChief Operating OfficerJul 2024
James J. QuinlanChief Financial OfficerJul 2024
Raza J. BokhariChairman and Chief Executive OfficerJul 2024
Barry J. FishmanDirectorJul 2024
Frank J. LavelleDirectorJul 2024
Larry KaiserDirectorJul 2024
Raza J. BokhariChairman and Chief Executive OfficerJul 2024
Robert J. CiaruffoliDirectorJul 2024
Sara R. MayDirectorJul 2024
William L. AshtonDirectorJul 2024

Went public since 2024. Its SEC number is that of a company listed on a stock exchange.